Welcoming our New Vice President of Development

The Max Foundation is pleased to announce the hiring of Wilma Comenat as Vice President of Development of The Max Foundation.

Wilma has more than 20 years of experience in the nonprofit sector leading development teams and driving major donor fundraising initiatives.

Her previous roles include the Associate Executive Director of JDRF Greater Northwest, Regional Director of Lupus Foundation of America, Inc.’s Pacific Northwest region, and Deputy Executive Director of The Leukemia & Lymphoma Society.

“As an ambitious organization, we knew we needed a leader with a breadth of experience who can push us to the next level,” says Patti Pearce, The Max Foundation CFO and VP of Administration. “I have total confidence in Wilma’s leadership and experience to drive success.”

Wilma will join The Max Foundation’s Seattle headquarters office and oversee The Max Foundation’s development and communication departments.

“I am honored to have the opportunity to join The Max Foundation,” says Wilma. “I’ve been impressed with the organization from the start and feel connected to the mission of providing dignity and hope to cancer patients worldwide.”

Please join us in welcoming Wilma Comenat as The Max Foundation’s Vice President of Development.

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

    The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

    IPIG joins Max’s Humanitarian Partnership for Access to Critical Treatments (Humanitarian PACT) and will provide medical education and training on PNH care and management Max will provide access to innovative treatment as part of the multi-stakeholder collaboration focused on eradicating survival disparities in 53 low-resource countries People living with this rare blood disease require frequent….

  • Partner physician article published in Clinical Surgical Oncology

    Partner physician article published in Clinical Surgical Oncology

    An article by one of our partner physicians, Dr. Freddy Gnangnon in Benin, was recently published in Clinical Surgical Oncology. It’s about the management of locally advanced gastrointestinal stromal tumors and how providing access to treatment free of charge improves survival outcomes. Read More

  • Welcoming two new members to our Strategic Innovation Advisory Board

    Welcoming two new members to our Strategic Innovation Advisory Board

    Graciela Mabel Woloj Rothstein and Mikkel Z. Oestergaard, PhD join the board this March